Cargando…
Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data
Model-informed precision dosing is being increasingly used to improve therapeutic drug monitoring. To meet this need, several tools have been developed, but open-source software remains uncommon. Posologyr is a free and open-source R package developed to enable Bayesian individual parameter estimati...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879752/ https://www.ncbi.nlm.nih.gov/pubmed/35214174 http://dx.doi.org/10.3390/pharmaceutics14020442 |
_version_ | 1784658973114236928 |
---|---|
author | Leven, Cyril Coste, Anne Mané, Camille |
author_facet | Leven, Cyril Coste, Anne Mané, Camille |
author_sort | Leven, Cyril |
collection | PubMed |
description | Model-informed precision dosing is being increasingly used to improve therapeutic drug monitoring. To meet this need, several tools have been developed, but open-source software remains uncommon. Posologyr is a free and open-source R package developed to enable Bayesian individual parameter estimation and dose individualization. Before using it for clinical practice, performance validation is mandatory. The estimation functions implemented in posologyr were benchmarked against reference software products on a wide variety of models and pharmacokinetic profiles: 35 population pharmacokinetic models, with 4.000 simulated subjects by model. Maximum A Posteriori (MAP) estimates were compared to NONMEM post hoc estimates, and full posterior distributions were compared to Monolix conditional distribution estimates. The performance of MAP estimation was excellent in 98.7% of the cases. Considering the full posterior distributions of individual parameters, the bias on dosage adjustment proposals was acceptable in 97% of cases with a median bias of 0.65%. These results confirmed the ability of posologyr to serve as a basis for the development of future Bayesian dose individualization tools. |
format | Online Article Text |
id | pubmed-8879752 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88797522022-02-26 Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data Leven, Cyril Coste, Anne Mané, Camille Pharmaceutics Article Model-informed precision dosing is being increasingly used to improve therapeutic drug monitoring. To meet this need, several tools have been developed, but open-source software remains uncommon. Posologyr is a free and open-source R package developed to enable Bayesian individual parameter estimation and dose individualization. Before using it for clinical practice, performance validation is mandatory. The estimation functions implemented in posologyr were benchmarked against reference software products on a wide variety of models and pharmacokinetic profiles: 35 population pharmacokinetic models, with 4.000 simulated subjects by model. Maximum A Posteriori (MAP) estimates were compared to NONMEM post hoc estimates, and full posterior distributions were compared to Monolix conditional distribution estimates. The performance of MAP estimation was excellent in 98.7% of the cases. Considering the full posterior distributions of individual parameters, the bias on dosage adjustment proposals was acceptable in 97% of cases with a median bias of 0.65%. These results confirmed the ability of posologyr to serve as a basis for the development of future Bayesian dose individualization tools. MDPI 2022-02-18 /pmc/articles/PMC8879752/ /pubmed/35214174 http://dx.doi.org/10.3390/pharmaceutics14020442 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Leven, Cyril Coste, Anne Mané, Camille Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data |
title | Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data |
title_full | Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data |
title_fullStr | Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data |
title_full_unstemmed | Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data |
title_short | Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data |
title_sort | free and open-source posologyr software for bayesian dose individualization: an extensive validation on simulated data |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879752/ https://www.ncbi.nlm.nih.gov/pubmed/35214174 http://dx.doi.org/10.3390/pharmaceutics14020442 |
work_keys_str_mv | AT levencyril freeandopensourceposologyrsoftwareforbayesiandoseindividualizationanextensivevalidationonsimulateddata AT costeanne freeandopensourceposologyrsoftwareforbayesiandoseindividualizationanextensivevalidationonsimulateddata AT manecamille freeandopensourceposologyrsoftwareforbayesiandoseindividualizationanextensivevalidationonsimulateddata |